AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 165 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $62,000 | -19.5% | 1,355 | -3.2% | 0.00% | 0.0% |
| Q2 2021 | $77,000 | -4.9% | 1,400 | -10.8% | 0.00% | 0.0% |
| Q1 2021 | $81,000 | +17.4% | 1,570 | -1.9% | 0.00% | -50.0% |
| Q4 2020 | $69,000 | +245.0% | 1,600 | +171.2% | 0.00% | +100.0% |
| Q3 2020 | $20,000 | +17.6% | 590 | +40.5% | 0.00% | -50.0% |
| Q4 2016 | $17,000 | -5.6% | 420 | +21.7% | 0.00% | 0.0% |
| Q3 2016 | $18,000 | +100.0% | 345 | +66.7% | 0.00% | +100.0% |
| Q2 2016 | $9,000 | +80.0% | 207 | +58.0% | 0.00% | – |
| Q1 2016 | $5,000 | +25.0% | 131 | +111.3% | 0.00% | – |
| Q4 2015 | $4,000 | – | 62 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,719,998 | $155,502,000 | 4.38% |
| Casdin Capital, LLC | 295,000 | $16,865,000 | 4.11% |
| Opaleye Management Inc. | 130,000 | $7,432,000 | 2.38% |
| Opus Point Partners Management, LLC | 28,704 | $1,641,000 | 1.42% |
| Fernwood Investment Management, LLC | 27,550 | $1,575,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 100,000 | $5,717,000 | 0.77% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 760,116 | $43,456,000 | 0.65% |
| Eventide Asset Management | 214,000 | $12,234,000 | 0.64% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 262,984 | $15,035,000 | 0.59% |
| CAPITAL GUARDIAN TRUST CO | 663,089 | $37,909,000 | 0.54% |